However, 2F-Fuc treatment obviously restored the tumor cells’ susceptibility to cytotoxic T-cell-mediated death in cells with re-expression of glycosylated B7H3 (Fig. 8b), suggesting that 2F-Fuc enhances T-cell activation mainly through the reduction of B7H3 core fucosylation. Here, CD276 is linked to neoplasm.